Preclinical Evaluation of Vemurafenib as Therapy for BRAFV600E Mutated Sarcomas.
about
Preclinical Evaluation of Vemurafenib as Therapy for BRAFV600E Mutated Sarcomas.
description
2018 nî lūn-bûn
@nan
2018年の論文
@ja
2018年学术文章
@wuu
2018年学术文章
@zh
2018年学术文章
@zh-cn
2018年学术文章
@zh-hans
2018年学术文章
@zh-my
2018年学术文章
@zh-sg
2018年學術文章
@yue
2018年學術文章
@zh-hant
name
Preclinical Evaluation of Vemurafenib as Therapy for BRAFV600E Mutated Sarcomas.
@en
Preclinical Evaluation of Vemurafenib as Therapy for BRAFV600E Mutated Sarcomas.
@nl
type
label
Preclinical Evaluation of Vemurafenib as Therapy for BRAFV600E Mutated Sarcomas.
@en
Preclinical Evaluation of Vemurafenib as Therapy for BRAFV600E Mutated Sarcomas.
@nl
prefLabel
Preclinical Evaluation of Vemurafenib as Therapy for BRAFV600E Mutated Sarcomas.
@en
Preclinical Evaluation of Vemurafenib as Therapy for BRAFV600E Mutated Sarcomas.
@nl
P2093
P2860
P356
P1476
Preclinical Evaluation of Vemurafenib as Therapy for BRAFV600E Mutated Sarcomas
@en
P2093
Leonardo A Meza-Zepeda
Ola Myklebost
Sarina Gouravan
P2860
P356
10.3390/IJMS19040969
P407
P577
2018-03-23T00:00:00Z